Showing results (1-10 of 94) with videos related to

Sort By:
Pageof 10
Current Opinion in Pharmacology|July 26, 2011
Understanding pharmacology in humans: Phase I and Phase II (data generation)Emilio Merlo Pich
European Neuropsychopharmacology : the Journal of the European College of Neuropsychopharmacology|June 4, 2011
Trial Simulation to estimate Type I error when a population window enrichment strategy is used to improve efficiency of clinical trials in depressionRoberto Gomeni, Emilio Merlo-Pich
Pharmacology, Biochemistry, and Behavior|June 22, 2002
Corticosterone administration to rat pups, but not maternal separation, affects sexual maturation and glucocorticoid receptor immunoreactivity in the testisGiuseppe Biagini, Emilio Merlo Pich
British Journal of Clinical Pharmacology|May 10, 2007
Bayesian modelling and ROC analysis to predict placebo responders using clinical score measured in the initial weeks of treatment in depression trialsRoberto Gomeni, Emilio Merlo-Pich
European Neuropsychopharmacology : the Journal of the European College of Neuropsychopharmacology|August 24, 2015
Pharmacological targeting of dopamine D3 receptors: Possible clinical applications of selective drugsEmilio Merlo Pich, Ginetta Collo
Frontiers in Neuroscience|March 5, 2014
Orexin 1 receptor antagonists in compulsive behavior and anxiety: possible therapeutic useEmilio Merlo Pich, Sergio Melotto
Chronic Stress (Thousand Oaks, Calif.)|May 23, 2020
Structural Plasticity Induced by Ketamine in Human Dopaminergic Neurons as Mechanism Relevant for Treatment-Resistant DepressionGinetta Collo, Laura Cavalleri, Emilio Merlo Pich
Handbook of Experimental Pharmacology|November 7, 2012
Biomarkers for antipsychotic therapiesEmilio Merlo Pich, Gabriel Vargas, Enrico Domenici
European Journal of Pharmaceutical Sciences : Official Journal of the European Federation for Pharmaceutical Sciences|December 2, 2008
Modelling placebo response in depression trials using a longitudinal model with informative dropoutRoberto Gomeni, Agnes Lavergne, Emilio Merlo-Pich
Neuroreport|December 27, 2018
Ketamine increases the expression of GluR1 and GluR2 α-amino-3-hydroxy-5-methy-4-isoxazole propionate receptor subunits in human dopaminergic neurons differentiated from induced pluripotent stem cellsGinetta Collo, Laura Cavalleri, Cristiano Chiamulera, et al.
Pageof 10